| All Releases |
 |
January 29, 2010
Warner Chilcott Announces 2010 Financial Guidance |
 |
 |
| |
ARDEE, Ireland, Jan 29, 2010 /PRNewswire via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today a view of anticipated full year 2010 results.
Adjusted total revenues for 2010, after excluding the impact of the Company's distribution agreement with LEO Pharma A/S ("LEO"), are expected to be in the range of $2.9 to $2.95 bil... |
|
|
January 27, 2010
FDA Issues Complete Response Letter for Low Dose Oral Contraceptive |
|
|
| |
ARDEE, Ireland, Jan 27, 2010 /PRNewswire via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it has received a complete response letter from the U.S. Food and Drug Administration (FDA) to its New Drug Application submitted in March 2009 for its "low dose" oral contraceptive (also referred to as WC 3016).
The letter... |
|
|
January 25, 2010
Warner Chilcott Announces 2010 Financial Guidance Conference Call |
|
|
| |
ARDEE, Ireland, Jan 25, 2010 /PRNewswire via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it will issue its 2010 Financial Guidance before market open on Friday, January 29, 2010. In addition to issuing a press release, Roger Boissonneault, President and Chief Executive Officer and Paul Herendeen, Executive Vice... |
|
|
January 5, 2010
Warner Chilcott to Present at the 28th Annual J.P. Morgan Healthcare Conference |
|
|
| |
ARDEE, Ireland, Jan 05, 2010 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it will present at the 28th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2010 at 11:30 a.m. PST. Presenting for Warner Chilcott will be Paul Herendeen, Executive Vice President and Chief Financi... |
|
|
December 30, 2009
Warner Chilcott Announces Early Tender Results and Receipt of Consents from a Majority of Holders of its 8-3/4% Senior Subordinated Notes due 2015 |
|
|
| |
ARDEE, Ireland, Dec 30, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced that its subsidiary Warner Chilcott Corporation (the "Company") has received and accepted for purchase approximately $290.5 million aggregate principal amount of its 8-3/4% Senior Subordinated Notes due 2015 (Cusip No. 9... |
|
|
December 15, 2009
Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 |
|
|
| |
ARDEE, Ireland, Dec 15, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced that its subsidiary Warner Chilcott Corporation (the "Company") has commenced a cash tender offer, on the terms and subject to the conditions set forth in the Company's Offer to Purchase and Consent Solicitation Statemen... |
|
|
December 15, 2009
Warner Chilcott Affirms Global Marketing and Collaboration Agreement With Sanofi-Aventis |
|
|
| |
ARDEE, Ireland, Dec 15, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that Sanofi-Aventis U.S. LLC ("Sanofi") has elected not to exercise its right to put its interest in the global marketing and collaboration agreement (the "Marketing Agreement"). As previously disclosed, Warner Chilcott... |
|
|
December 11, 2009
Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes |
|
|
| |
ARDEE, Ireland, Dec 11, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- As Warner Chilcott plc (Nasdaq: WCRX) has previously disclosed, its acquisition of the global branded prescription pharmaceuticals business of The Procter & Gamble Company ("P&G") on October 30, 2009 (the "PGP Acquisition"), constituted a change of control under a global... |
|
|
November 19, 2009
Warner Chilcott Prices Secondary Equity Offering |
|
|
| |
ARDEE, Ireland, Nov 19, 2009 /PRNewswire via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced the pricing of its previously announced secondary offering of 20,000,000 of its ordinary shares at a price to the public of $22.25 per share. The selling shareholders include funds affiliated with Bain Capital Partners, DLJ Merch... |
|
|
November 13, 2009
Warner Chilcott Announces Secondary Equity Offering |
|
|
| |
ARDEE, Ireland, Nov 13, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced a 20,000,000 share secondary offering of its ordinary shares by certain selling shareholders. The selling shareholders include funds affiliated with Bain Capital Partners, DLJ Merchant Banking, J.P. Morgan Partners (adv... |
|
|
November 9, 2009
Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2009 |
|
|
| |
ARDEE, Ireland, Nov 09, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced its results for the quarter ended September 30, 2009. Revenue in the quarter ended September 30, 2009 increased 9.0% to $252.8 million over the prior year quarter. The primary drivers of the increase in revenue in the qu... |
|
|
November 2, 2009
Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2009 Financial Results |
|
|
| |
ARDEE, Ireland, Nov 02, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it will issue its third quarter 2009 financial results prior to the market opening on Monday, November 9, 2009.
In addition to issuing a press release, the Company will host a conference call for all interested par... |
|
|
October 30, 2009
Warner Chilcott Completes Acquisition of P&G's Global Branded Prescription Pharmaceuticals Business |
|
|
| |
ARDEE, Ireland, Oct 30, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today it has completed the acquisition of The Procter & Gamble Company's global branded prescription pharmaceutical business. The acquisition complements Warner Chilcott's existing presence in women's health care and adds new... |
|
|
October 20, 2009
Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development |
|
|
| |
ARDEE, Ireland, Oct 20, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that Dr. Mahdi Fawzi has joined the company as President, Global Research and Development. He joins Warner Chilcott from Wyeth Pharmaceuticals, where he was responsible for directing global preclinical development activ... |
|
|
September 23, 2009
LEO Pharma Repurchases Product Rights From Warner Chilcott |
|
|
| |
ARDEE, Ireland and COPENHAGEN, Sept 23, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) and LEO Pharma announced today that, in exchange for a one-time cash payment of $1.0 billion to Warner Chilcott, LEO Pharma is re-acquiring Warner Chilcott's exclusive product licensing rights in the United States to its... |
|
|
September 10, 2009
Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents |
|
|
| |
ARDEE, Ireland, Sept 10, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that one of its subsidiaries has filed two lawsuits against Lupin Limited and its wholly owned subsidiary Lupin Pharmaceuticals, Inc. (collectively "Lupin") in the District Court for the District of Delaware for infring... |
|
|
August 24, 2009
Warner Chilcott Acquires P&G's Global Pharmaceuticals Business |
|
|
| |
CINCINNATI and ARDEE, Ireland, Aug 24, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- The Procter & Gamble Company (NYSE: PG) and Warner Chilcott plc (Nasdaq: WCRX) today announced an agreement for the sale of P&G's global pharmaceuticals business to Warner Chilcott for an up-front cash payment of $3.1 billion.
To view the Multimedia News ... |
|
|
August 21, 2009
Warner Chilcott Completes Irish Redomestication |
|
|
| |
ARDEE, Ireland, Aug 21, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott (Nasdaq: WCRX) announced today that its redomestication has been completed and the ultimate public holding company of the Warner Chilcott group is now organized in, and a tax resident of, Ireland. The transaction was completed on August 20, 2009, followi... |
|
|
August 7, 2009
Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance |
|
|
| |
ARDEE, Ireland, Aug 07, 2009 /PRNewswire-Firstcall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter ended June 30, 2009. Revenue in the quarter ended June 30, 2009 increased 7.1% to $250.8 million over the prior year quarter. The primary drivers of the increase in revenue were the net sa... |
|
|
August 5, 2009
Warner Chilcott Announces Shareholder Approval of Irish Redomestication |
|
|
| |
ARDEE, Ireland, Aug 05, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that at a special court-ordered meeting of shareholders held earlier today (the "Special Meeting"), its shareholders approved a scheme of arrangement between the Company and its shareholders. Assuming receipt of the... |
|
|
|
Investor Relations
